BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• ESSA Pharma to Present at JMP Securities Life Sciences Conference

  ESSA Pharma Inc. today announced that the Company will be presenting at the JMP Securities Life Sciences Conference on Tuesday, May 16, 2023 at 10:00 a.m. Eastern Time in New York.

  May 11, 2023

   · 

  1 min read
• Business

  Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results

  Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and financial results for the first quarter ended March 31, 2023.

  May 11, 2023

   · 

  14 min read
• Business

  Monte Rosa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update

  Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company developing novel molecular glue degrader -based medicines, reported business highlights and financial results for the quarter ended March 31, 2023.

  May 11, 2023

   · 

  11 min read
• Business

  Vera Therapeutics Provides Business Update and Reports First Quarter Financial Results

  Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today reported its business updates and financial results for the first quarter ended March 31, 2023.

  May 11, 2023

   · 

  8 min read
• Business

  Abeona Therapeutics Reports First Quarter 2023 Financial Results

  Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the first quarter of 2023 and provided an update on progress toward achieving key corporate objectives.

  May 11, 2023

   · 

  8 min read
• Business

  GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights

  GH Research PLC today reported financial results for the first quarter ended March 31, 2023 and provided business highlights.

  May 11, 2023

   · 

  8 min read
• Business

  Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023

  Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today reports its financial results and provides an update on operational progress for the first quarter ended March 31, 2023.

  May 11, 2023

   · 

  12 min read
• Business

  Crescita Reports First Quarter 2023 Results

  Crescita Therapeutics Inc. today reported its financial results for the first quarter ended March 31, 2023 (“Q1-F2023”).

  May 11, 2023

   · 

  12 min read
• Business

  Reneo Pharmaceuticals Reports First Quarter 2023 Financial Results

  Reneo Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2023 and provided a business update.

  May 11, 2023

   · 

  9 min read
• Genetown

  Oculis Co-founders Selected as Finalists in European Inventor Award 2023

  Oculis Holding AG announced the nomination of its co-founders, Professors Einar Stefánsson and Thorsteinn Loftsson, as finalists in the ‘Research’ category of the European Inventor Award 2023.

  May 11, 2023

   · 

  5 min read